Microvascular disease and endothelial dysfunction in chronic kidney diseases: Therapeutic implication

Clinical Hemorheology and Microcirculation

Volumn 34, Issue 1-2, 2006, Pages 265-271

  Futrakul, Narisa ^a   Butthep, Punnee ^a   Patumraj, Suthiluk ^a   Siriviriyakul, Prasong ^a   Futrakul, Prasit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic kidney disease; Endothelial cell injury; Hemodynamics; Microvascular disease; Transforming growth factor beta (TGFB); VEGF

Indexed keywords

BIOLOGICAL MARKER; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ARTERIOLE; CAPILLARY FLOW; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROANGIOPATHY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENDOTHELIAL CELLS; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY DISEASES; MICROCIRCULATION; RENAL CIRCULATION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES;

EID: 33644803789     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. A. Bohle, S. Mackensen-Haen and M. Wehrmann, Significance of postglomerular capillaries in the pathogenesis of chronic renal failure, Kidney Blood Press. Res. 19 (1996), 191-195.
2. S. Yenrudi, A. Laohapaibul, W. Kittidiwit, S. Suteparuk and N. Futrakul, A correlation between renal morphology and renal circulation in pediatric nephrotic syndrome, Ren. Fail. 23 (2001), 85-90.
3. D.H. Kang, J. Kanellis, C. Hugo, L. Truong, S. Anderson, D. Kerjaschki, G.F. Schreiner and R.J. Johnson, Role of microvascular endothelium in progressive renal disease, J. Am. Soc. Nephrol. 13 (2002), 806-816.
4. N. Futrakul, W. Kittikowit and S. Yenrudi, Reduced endothelial factor VIII staining in renal microcirculation correlates with hemodynamic alteration in nephrosis, Ren. Fail. 25 (2003), 759-764.
5. A. Solovey, Y. Lin, P. Browne, S. Choong, E. Wayner and P.R. Hebbel, Circulating activated endothelial cells in sickle cell anemia, N. Engl. J. Med. 337 (1997), 1584-1590.
6. N. Futrakul, P. Futrakul and P. Siriviriyakul, Correction of peritubular capillary flow reduction with vasodilators restores function in focal segmental glomerulosclerotic nephrosis, Clin. Hemorheol. Microcirc. 31 (2004), 197-205.
7. D.M. Gomez, Evaluation of renal resistance, with special reference to change in essential hypertension, J. Clin. Invest. 30 (1951), 1143-1155.
8. A. Guasch, R.K. Sibley, P. Huie and B.D. Meyers, Extent and course of glomerular injury in human membranous glomerulopathy, Am. J. Physiol. 263 (1992), F1034-F1043.
9. P. Futrakul, S. Yenrudi, N. Futrakul, R. Sensirivatana, P. Kingwatanakul, J. Jungthirapanich, T. Cherdkiadtikul, A. Laohapaibul, D. Watana, V. Singkhwa, S. Futrakul and P. Pongsin, Tubular function and tubulointerstitial disease, Am. J. Kidney Dis. 33 (1999), 886-891.
10. N. Futrakul and P. Futrakul, Microvascular disease and renal disease progression, J. Med. Assoc. Thai (in press).
11. N. Futrakul, P. Tosukhowong, Y. Valyapongpichit, N. Tipprukmas, P. Futrakul and S. Patumraj, Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication, Ren. Fail. 24 (2002), 433-445.
12. N. Futrakul, P. Sirivirayakul, T. Panichakul, P. Butthep, S. Patumraj and P. Futrakul, Glomerular endothelial cytotoxicity and dysfunction in nephrosis with focal segmental glomerulosclerosis, Clin. Hemorheol. Microcirc. 29 (2003), 469-473.
13. M. Schiffer, M. Bitzer, I.S. Roberts, J.B. Kopp, P. ten Dijke, P. Mundel and E.P. Bottinger, Apoptosis in podocytes induced by TGF-beta and Smad 7, J. Clin. Invest. 108 (2001), 807-816.
14. A. Miyajima, J. Chen, C. Lawrence, S. Ledbetter, R.A. Soslow, J. Stern, S. Jha, J. Pigato, M.L. Lemer, D.P. Poppas, E.D. Vaughan and D. Felson, Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral obstruction, Kidney Int. 58 (2000), 2301-2313.
15. P. Futrakul, P. Siriviriyakul, S. Patumraj, S. Bunnag, O. Kulaputana and N. Futrakul, A hemodynamically mediated mechanism of renal disease progression in severe glomerulonephritides or nephrosis, Clin. Hemorheol. Microcirc. 29 (2003), 183-187.
16. N. Futrakul, M. Boonyen, S. Patumraj, P. Siriviriyakul, P. Tosukhowong and P. Futrakul, Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators, Clin. Hemorheol. Microcirc. 29 (2003), 205-210.
17. N. Futrakul, A. Laohapaibul and P. Futrakul, Glomerular endothelial dysfunction and hemodynamic maladjustment in vesicoureteric reflux, Ren. Fail. 25 (2003), 479-483.
18. N. Futrakul, P. Butthep, V. Vongthavarawat, P. Futrakul, S. Sirisalipoch, T. Chaiwatanarat et al., Early detection of endothelial injury and dysfunction in conjunction with corretion of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy, Clin. Hemorheol. Microcirc. (in press).
19. N. Futrakul, S. Yenrudi, R. Sensirivatana, D. Watana, A. Laohapaibul, K. Watanapenphaibul and S. Futrakul, Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome, Ren. Fail. 22 (2000), 329-335.
20. K. Manotham, T. Tanaka, M. Matsumoto, T. Ohse, R. Inagi, T. Miyato, K. Kurokawa, T. Fujita, J.R. Ingelfinger and M. Nangaku, Transdifferentiation of cultured tubular cells induced by hypoxia, Kidney Int. 65 (2004), 871-880.
21. N. Futrakul, P. Tohsukhowong, S. Patumraj, P. Siriviriyakul, N. Tipprukmas, P. Futrakul, Treatment of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chrornically severe glomerulonephritides, Ren. Fail. 25 (2003), 839-844.
22. R. Campbell, F. Sangalli, E. Perticucci, C. Aros, C. Viscarra, A. Perna, A. Remuzzi, F. Bertocchi, L. Fagiani and G. Remuzzi, Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies, Kidney Int. 63 (2003), 1094-1110.
23. P. Ruggenenti, A. Perna, R. Benini, T. Bertani, C. Zoccali, Q. Maggiore, M. Salvadori and G. Remuzzi, In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR, J. Am. Soc. Nephrol. 10 (1999), 997-1006.
24. J.T. Wright, Jr, G. Bakris, T. Greene, L.Y. Agodea, L.J. Appel, J. Charleston, D. Cheek, J.G. Douglas-Baltimore, J. Gassman, R. Glassok, L. Hebert, K. Jamerson, J. Lewis, R.A. Phillips, R.D. Toto, J.P. Middleton and S.G. Rostand, Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease, Results from the AASK Trail, J.A.M.A. 228 (2002), 2421-2431.
25. H.H. Parving, Diabetic nephropathy: Prevention and treatment, Kidney Int. 60 (2001), 2041-2055.
26. The GISEN Group, Randomized placebo controlled trial of effect of Ramipril on decline in glomerules filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy, Lancet 349 (1997), 1857-1863.